Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
I just got my 2nd shot and the fever had me in bed for 2 days; I just got my 2nd shot and the headache had me in bed for 2 days; me in bed for 2 days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: I just got my 2nd shot and the fever had me in bed for 2 days), headache (Verbatim: I just got my 2nd shot and the headache had me in bed for 2 days) and bedridden (Verbatim: me in bed for 2 days). Rechallenge with Shingles vaccine was positive. The outcome of the fever and headache were not reported and the outcome of the bedridden was resolved (duration 2 days). It was unknown if the reporter considered the fever, headache and bedridden to be related to Shingles vaccine. It was unknown if the company considered the fever, headache and bedridden to be related to Shingles vaccine. Linked case(s) involving the same patient:US2026AMR020652 Additional Information: GSK Receipt Date: 07-FEB-2026 This case was reported by a patient via interactive digital media. The patient just got his/her 2nd shot and the fever and headache had him/her in bed for 2 days. The batch number was not provided and follow up not possible. For tolerance of 1st dose of Shingles vaccine, refer case US2026AMR020652; Sender's Comments: US-GSK-US2026AMR020652:SAME PATIENT